These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 22832492)

  • 21. Antileukemic activity of nuclear export inhibitors that spare normal hematopoietic cells.
    Etchin J; Sun Q; Kentsis A; Farmer A; Zhang ZC; Sanda T; Mansour MR; Barcelo C; McCauley D; Kauffman M; Shacham S; Christie AL; Kung AL; Rodig SJ; Chook YM; Look AT
    Leukemia; 2013 Jan; 27(1):66-74. PubMed ID: 22847027
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Casein-kinase-II-dependent phosphorylation of PPARgamma provokes CRM1-mediated shuttling of PPARgamma from the nucleus to the cytosol.
    von Knethen A; Tzieply N; Jennewein C; Brüne B
    J Cell Sci; 2010 Jan; 123(Pt 2):192-201. PubMed ID: 20026644
    [TBL] [Abstract][Full Text] [Related]  

  • 23. RanBP3 Regulates Melanoma Cell Proliferation via Selective Control of Nuclear Export.
    Pathria G; Garg B; Wagner C; Garg K; Gschaider M; Jalili A; Wagner SN
    J Invest Dermatol; 2016 Jan; 136(1):264-74. PubMed ID: 26763446
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Insights into the function of the CRM1 cofactor RanBP3 from the structure of its Ran-binding domain.
    Langer K; Dian C; Rybin V; Müller CW; Petosa C
    PLoS One; 2011 Feb; 6(2):e17011. PubMed ID: 21364925
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Kinetic and molecular analysis of nuclear export factor CRM1 association with its cargo in vivo.
    Daelemans D; Costes SV; Lockett S; Pavlakis GN
    Mol Cell Biol; 2005 Jan; 25(2):728-39. PubMed ID: 15632073
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Expression, function, and targeting of the nuclear exporter chromosome region maintenance 1 (CRM1) protein.
    Ishizawa J; Kojima K; Hail N; Tabe Y; Andreeff M
    Pharmacol Ther; 2015 Sep; 153():25-35. PubMed ID: 26048327
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Silencing FLI or targeting CD13/ANPEP lead to dephosphorylation of EPHA2, a mediator of BRAF inhibitor resistance, and induce growth arrest or apoptosis in melanoma cells.
    Azimi A; Tuominen R; Costa Svedman F; Caramuta S; Pernemalm M; Frostvik Stolt M; Kanter L; Kharaziha P; Lehtiö J; Hertzman Johansson C; Höiom V; Hansson J; Egyhazi Brage S
    Cell Death Dis; 2017 Aug; 8(8):e3029. PubMed ID: 29048432
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The export receptor Crm1 forms a dimer to promote nuclear export of HIV RNA.
    Booth DS; Cheng Y; Frankel AD
    Elife; 2014 Dec; 3():e04121. PubMed ID: 25486595
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Molecular Characterization and Functional Analysis of Annulate Lamellae Pore Complexes in Nuclear Transport in Mammalian Cells.
    Raghunayakula S; Subramonian D; Dasso M; Kumar R; Zhang XD
    PLoS One; 2015; 10(12):e0144508. PubMed ID: 26642330
    [TBL] [Abstract][Full Text] [Related]  

  • 30. STRADalpha regulates LKB1 localization by blocking access to importin-alpha, and by association with Crm1 and exportin-7.
    Dorfman J; Macara IG
    Mol Biol Cell; 2008 Apr; 19(4):1614-26. PubMed ID: 18256292
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prognostic impact and targeting of CRM1 in acute myeloid leukemia.
    Kojima K; Kornblau SM; Ruvolo V; Dilip A; Duvvuri S; Davis RE; Zhang M; Wang Z; Coombes KR; Zhang N; Qiu YH; Burks JK; Kantarjian H; Shacham S; Kauffman M; Andreeff M
    Blood; 2013 May; 121(20):4166-74. PubMed ID: 23564911
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The nucleoporin-like protein NLP1 (hCG1) promotes CRM1-dependent nuclear protein export.
    Waldmann I; Spillner C; Kehlenbach RH
    J Cell Sci; 2012 Jan; 125(Pt 1):144-54. PubMed ID: 22250199
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Importins and exportins as therapeutic targets in cancer.
    Mahipal A; Malafa M
    Pharmacol Ther; 2016 Aug; 164():135-43. PubMed ID: 27113410
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Atomic basis of CRM1-cargo recognition, release and inhibition.
    Fung HY; Chook YM
    Semin Cancer Biol; 2014 Aug; 27():52-61. PubMed ID: 24631835
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The Crm de la crème of mitosis.
    Clarke PR
    Nat Cell Biol; 2005 Jun; 7(6):551-2. PubMed ID: 15928702
    [No Abstract]   [Full Text] [Related]  

  • 36. Survivin withdrawal by nuclear export failure as a physiological switch to commit cells to apoptosis.
    Chan KS; Wong CH; Huang YF; Li HY
    Cell Death Dis; 2010 Jul; 1(7):e57. PubMed ID: 21364662
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Nucleocytoplasmic shuttling and the biological activity of mouse survivin are regulated by an active nuclear export signal.
    Stauber RH; Rabenhorst U; Rekik A; Engels K; Bier C; Knauer SK
    Traffic; 2006 Nov; 7(11):1461-72. PubMed ID: 16984408
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The RanBP2/RanGAP1*SUMO1/Ubc9 SUMO E3 ligase is a disassembly machine for Crm1-dependent nuclear export complexes.
    Ritterhoff T; Das H; Hofhaus G; Schröder RR; Flotho A; Melchior F
    Nat Commun; 2016 May; 7():11482. PubMed ID: 27160050
    [TBL] [Abstract][Full Text] [Related]  

  • 39. p53 SUMOylation promotes its nuclear export by facilitating its release from the nuclear export receptor CRM1.
    Santiago A; Li D; Zhao LY; Godsey A; Liao D
    Mol Biol Cell; 2013 Sep; 24(17):2739-52. PubMed ID: 23825024
    [TBL] [Abstract][Full Text] [Related]  

  • 40. CBS9106 is a novel reversible oral CRM1 inhibitor with CRM1 degrading activity.
    Sakakibara K; Saito N; Sato T; Suzuki A; Hasegawa Y; Friedman JM; Kufe DW; Vonhoff DD; Iwami T; Kawabe T
    Blood; 2011 Oct; 118(14):3922-31. PubMed ID: 21841164
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.